InSightec is conducting several clinical trials around the world to evaluate the safety and efficacy of the ExAblate MRgFUS system in relieving pain due to bone metastases and multiple myeloma. This non-invasive outpatient procedure, which does not involve any ionizing radiation, destroys the pain-causing nerves in the bone surface surrounding the tumor in order to relieve pain.
In most cases the treatment will involve one session.
The clinical studies and participating sites are:
Randomized Trial comparing ExAblate MRgFUS (Magnetic Resonance-guided Focused Ultrasound Surgery) treatment of Metastatic and Multiple Myeloma Bone Tumors for the palliation of pain in patients and a Sham (no) treatment for patients who are not candidates for Radiation Therapy.
Click here to view participating sites.
Link to Clinical Trials.gov
____________________________________________________
(Outside USA) Study to Evaluate the Effectiveness and Safety of ExAblate MRgFUS treatment of Metastatic Bone Tumors for the palliation of pain in patients who are not candidates for Radiation Therapy.
Click here to view participating sites.
____________________________________________________
Study to evaluate the effectiveness and safety of treatment by MR guided High Intensity focused ultrasound using conformal system in patients with pain from metastatic bone disease.
Click here to view participating sites.
_____________________________________________________
In this study the tumor will be treated either by external ionizing radiation or by MR guided high-intensity focused ultrasound. The purpose of this study is to gather data, to compare the effectiveness and safety of the two treatments.
Click here to view participating sites.
Link to Clinical Trials.gov
